Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24686417

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer

Author
ARGIRIS, Athanassios1 2 3 ; LEE, Steve C3 ; FEINSTEIN, Trevor2 ; THOMAS, Sufi3 ; BRANSTETTER IV, Barton F3 4 ; SEETHALA, Raja5 ; LIN WANG3 5 ; GOODING, William1 6 ; GRANDIS, Jennifer R1 3 ; FERRIS, Robert L1 3 7
[1] Head and Neck Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States
[2] Division of Hematology-Oncology, University of Pittsburgh Medical School, Pittsburgh, PA, United States
[3] Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
[4] Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
[5] Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
[6] Biastatistics Facility, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States
[7] Cancer Immunology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States
Source

Oral oncology (1997). 2011, Vol 47, Num 10, pp 961-966, 6 p ; ref : 34 ref

ISSN
1368-8375
Scientific domain
Medical oncology; Otorhinolaryngology, stomatology, dentistry
Publisher
Elsevier, Kidlington
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
Cetuximab Cytokines Epidermal growth factor receptor Head and neck cancer Interleukin-6 Tumor markers Vascular endothelial growth factor
Keyword (fr)
Anticancéreux Cancer de la tête et du cou Cancérologie Cytokine Cétuximab Facteur croissance endothélium vasculaire Facteur croissance épiderme Facteur prédictif Immunomodulateur Interleukine 6 Marqueur biologique Marqueur tumoral ORL Récepteur facteur croissance Stomatologie Sérum Traitement Anti-EGFR Anticorps monoclonal Cancer Pathologie ORL Récepteur facteur croissance épiderme Tumeur maligne
Keyword (en)
Antineoplastic agent Head and neck cancer Cancerology Cytokine Cetuximab Vascular endothelium growth factor Epidermal growth factor Predictive factor Immunomodulator Interleukin 6 Biological marker Tumoral marker ENT Growth factor receptor Stomatology Serum Treatment Monoclonal antibody Cancer ENT disease Epidermal growth factor receptor Malignant tumor
Keyword (es)
Anticanceroso Cáncer de cabeza y cuello Cancerología Citoquina Cetuximab Factor crecimiento endotelio vascular Factor de crecimiento epidérmico Factor predictivo Inmunomodulador Interleuquina 6 Marcador biológico Marcador tumoral ORL Receptor factor crecimiento Estomatología Suero Tratamiento Anticuerpo monoclonal Cáncer ORL patología Receptor del factor de crecimiento epidérmico Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10A Otorhinolaryngology (head neck, general aspects and miscellaneous) / 002B10A01 Tumors

Discipline
Otorhinolaryngology. Stomatology Pharmacological treatments Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
24686417

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web